PubMed · 7122906
Early pregnancy-abortion model using sulprostone.
Abstract
Sulprostone has been demonstrated to be effective as a parenteral abortifacient, but not as a vaginal suppository. A vaginal preparation was given to 19 women to determine its mechanism of action, and to confirm the principle of uterine conversion as a biological model for the induction of an early abortion. The drug was administered to women with confirmed pregnancies and amenorrhea and not exceeding 49 days. A 95% success rate was obtained with an incidence of drug related side effects of 20% as opposed to the general 80-90% figure of PGE2 and F2a. The hormone profile obtained revealed a parallel fall in hCG and estradiol, and progesterone. This study confirms the value of uterine conversion, a concept that describes the change in uterine reactivity following PG administration and determines the phase when uterine activity is no longer dependent on exogenous oxytocic medication.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
A Fleischer, H Schulman, P Blattner, N Jagani, A Fayemi. 1982. Early pregnancy-abortion model using sulprostone.. https://doi.org/10.1016/s0090-6980(82)80004-x
Cite the original work for its findings. Save a collection to share your selection of sources.